Comera Life Sciences is a formulation innovator for protein therapeutics. Our proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using our platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient to produce. By enhancing therapeutic protein formulations, Comera’s technology helps to turn biologic molecules into biobetters in order to improve the patient experience. In addition, our formulation advancements offer an opportunity for extending a product’s lifecycle. Founded by David Soane, a prolific entrepreneur in the advanced materials, polymer chemistry, and surface science fields, Comera is led by a team of experienced scientists who are creative, versatile, and enthusiastic about our technology. If you’re interested in joining us, visit our careers page. Technologies include: * Viscosity-reducing excipients for high concentration biologic formulations, to enable subcutaneous injection or device-assisted administration, or to improve filtration unit operations. * Stability-enhancing excipients, to prevent aggregation and particle formation in biologics. * Surfactant-replacing excipients, to avoid the degradation problems that accompany known surfactants for biological formulations.